Seres Therapeutics (1S90.F) Q3 2025 Earnings

6AugConfirmed
Q1 2025
Q2 2025
Q3 2025
-3.62
-1.31
1
3.32

Details

Expected EPS
-2.1349758
Actual EPS
-1.9463434
Surprise EPS
0.19
Surprise Percent
+8.84%

Description

Seres Therapeutics (1S90.F) has reported earnings of -1.9463434 per share for Q3 2025.

0 Comments

Share your thoughts